Status:
RECRUITING
Prognostic Impact of Lesion-specific Hemodynamic Index in Patients With Coronary Artery Disease
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Keimyung University Dongsan Medical Center
Inje University
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
20+ years
Brief Summary
The investigators aim to investigate the additive prognostic value of lesion-specific hemodynamic index such as ΔFFR, non-hyperemic pressure ratio such as RFR, over % diameter stenosis and FFR accordi...
Detailed Description
Fractional flow reserve (FFR)-based revascularization is the currently best practice recommended by guidelines. In addition to the use of coronary physiological indices as a vessel-specific metric, re...
Eligibility Criteria
Inclusion
- Age ≥20 years
- All comers who underwent successful FFR measurement and pullback tracing
Exclusion
- Chronic renal failure (estimated glomerular filtration rate \<30)
- ST-elevation myocardial infarction within 72 hours or previous coronary artery bypass graft surgery history
- Primary myocardial or valvular disease
- Left ventricular ejection fraction \< 30%
- Hemodynamically unstable clinical conditions
- Life expectancy \< 2 years
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
2429 Patients enrolled
Trial Details
Trial ID
NCT05250557
Start Date
August 1 2021
End Date
December 31 2026
Last Update
February 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-744